{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:31:15Z","timestamp":1761611475588,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nursing Clinics of North America"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.cnur.2019.02.008","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T04:50:10Z","timestamp":1553748610000},"page":"193-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tuberculosis"],"prefix":"10.1016","volume":"54","author":[{"given":"Ana M.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"World Health Organization","key":"10.1016\/j.cnur.2019.02.008_bib1"},{"issue":"6","key":"10.1016\/j.cnur.2019.02.008_bib2","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/313562","article-title":"Old Testament biblical references to tuberculosis","volume":"29","author":"Daniel","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cnur.2019.02.008_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0277-9536(01)00176-9","article-title":"The resurgence of disease: social and historical perspectives on the \u2018new\u2019 tuberculosis","volume":"55","author":"Gandy","year":"2002","journal-title":"Soc Sci Med"},{"author":"World Health Organization","key":"10.1016\/j.cnur.2019.02.008_bib4"},{"issue":"11","key":"10.1016\/j.cnur.2019.02.008_bib5","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6711a2","article-title":"Tuberculosis \u2013 United States, 2017","volume":"67","author":"Stewart","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"author":"Government of Canada","key":"10.1016\/j.cnur.2019.02.008_bib7"},{"key":"10.1016\/j.cnur.2019.02.008_bib8","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"Getahun","year":"2015","journal-title":"N\u00a0Engl J Med"},{"year":"2008","series-title":"Control of communicable diseases manual","author":"Heyman","key":"10.1016\/j.cnur.2019.02.008_bib9"},{"key":"10.1016\/j.cnur.2019.02.008_bib10","first-page":"1","article-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005","volume":"54","author":"Jensen","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"10.1016\/j.cnur.2019.02.008_bib11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.5588\/ijtld.13.0834","article-title":"Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis","volume":"18","author":"Dharmadhikari","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"10.1016\/j.cnur.2019.02.008_bib12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jama.2016.10357","article-title":"Primary care screening and treatment for latent tuberculosis infection in adults. Evidence report and systematic review for the US Preventative Services Task Force","volume":"316","author":"Kahwati","year":"2016","journal-title":"JAMA"},{"issue":"RR05","key":"10.1016\/j.cnur.2019.02.008_bib13","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection \u2013- United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cnur.2019.02.008_bib14","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw694","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"57","key":"10.1016\/j.cnur.2019.02.008_bib15","article-title":"Higher positivity rate with fourth-generation QuantiFERON-TB Gold Plus assay in low-risk US health care workers","volume":"2","author":"Hogan","year":"2019","journal-title":"J\u00a0Clin Microbiol"},{"issue":"7","key":"10.1016\/j.cnur.2019.02.008_bib16","doi-asserted-by":"crossref","first-page":"e00614","DOI":"10.1128\/JCM.00614-18","article-title":"Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon gamma release assays in patients at risk for tuberculosis and in health care workers","volume":"56","author":"Theel","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"issue":"7","key":"10.1016\/j.cnur.2019.02.008_bib17","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"year":"2016","series-title":"Drug-resistant tuberculosis: a survival guide for clinicians, third edition","key":"10.1016\/j.cnur.2019.02.008_bib18"},{"issue":"3","key":"10.1016\/j.cnur.2019.02.008_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJMoa1604544","article-title":"Transmission of extensively drug-resistant tuberculosis in South Africa","volume":"376","author":"Shah","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cnur.2019.02.008_bib21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.mcna.2013.03.012","article-title":"Multidrug-resistant tuberculosis","volume":"97","author":"Lynch","year":"2013","journal-title":"Med Clin North Am"},{"issue":"9","key":"10.1016\/j.cnur.2019.02.008_bib22","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.cnur.2019.02.008_bib23","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/ASO1E vaccine to prevent tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.cnur.2019.02.008_bib24","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","article-title":"Priorities for the treatment of latent tuberculosis infection in the United States","volume":"350","author":"Horsburgh","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cnur.2019.02.008_bib26","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/ije\/dyr058","article-title":"The incubation period distribution of tuberculosis estimated with a molecular epidemiological approach","volume":"40","author":"Borgdorff","year":"2011","journal-title":"Int J Epidemiol"},{"issue":"25","key":"10.1016\/j.cnur.2019.02.008_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.15585\/mmwr.mm6725a5","article-title":"Update of recommendations for use of once-weekly isoniazid-rifapentine regimen to treat latent Mycobacterium tuberculosis infection","volume":"67","author":"Borisov","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9332","key":"10.1016\/j.cnur.2019.02.008_bib29","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(02)09742-8","article-title":"Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug \u2013susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial","volume":"360","year":"2002","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.cnur.2019.02.008_bib30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/M17-1150","article-title":"Self-administered versus directly observed once-weekly isoniazid and rifapentine treatment of latent tuberculosis infection: a randomized trial","volume":"167","author":"Belknap","year":"2017","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.cnur.2019.02.008_bib31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1086\/596606","article-title":"Evaluation of the effect of treatment of latent tuberculosis infection on QuantiFERON-TB Gold Assay results","volume":"30","author":"Pollock","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cnur.2019.02.008_bib33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ajic.2016.12.017","article-title":"Delayed tuberculosis diagnosis and costs of contact investigations for hospital exposure: New York City, 2010 \u2013 2014","volume":"45","author":"Kelly","year":"2017","journal-title":"Am J Infect Control"}],"container-title":["Nursing Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0029646519300088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0029646519300088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T09:28:15Z","timestamp":1758446895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0029646519300088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0029646519300088"],"URL":"https:\/\/doi.org\/10.1016\/j.cnur.2019.02.008","relation":{},"ISSN":["0029-6465"],"issn-type":[{"type":"print","value":"0029-6465"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Nursing Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cnur.2019.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}